Tencent has begun a clinical trial in London of an artificial intelligence program that aims to diagnose patients with Parkinson’s disease, in partnership with a little-known British start-up called Medopad.
騰訊(Tencent)利用人工智能(AI)為帕金森病患者診斷的項目開始在倫敦進行臨床試驗,這一項目是與一家鮮為人知的英國初創(chuàng)企業(yè)Medopad合作進行的。
您已閱讀5%(284字),剩余95%(5326字)包含更多重要信息,訂閱以繼續(xù)探索完整內(nèi)容,并享受更多專屬服務(wù)。